Olaparib for Metastatic Germline BRCA-Mutated Breast Cancer
- PMID: 29094857
- DOI: 10.1056/NEJMc1711644
Olaparib for Metastatic Germline BRCA-Mutated Breast Cancer
Comment in
-
Olaparib for Metastatic Germline BRCA-Mutated Breast Cancer.N Engl J Med. 2017 Nov 2;377(18):1792-3. doi: 10.1056/NEJMc1711644. N Engl J Med. 2017. PMID: 29091556 No abstract available.
Comment on
-
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.N Engl J Med. 2017 Aug 10;377(6):523-533. doi: 10.1056/NEJMoa1706450. Epub 2017 Jun 4. N Engl J Med. 2017. PMID: 28578601 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical